Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

被引：130

作者：

Husted, Steen

de Caterina, Raffaele ^{[1
,2
]}

Andreotti, Felicita ^{[3
]}

Arnesen, Harald ^{[4
]}

Bachmann, Fedor ^{[5
]}

Huber, Kurt ^{[6
]}

Jespersen, Jorgen ^{[7
]}

Kristensen, Steen Dalby ^{[8
]}

Lip, Gregory Y. H. ^{[9
]}

Morais, Joao ^{[10
]}

Rasmussen, Lars H. ^{[11
,12
]}

Siegbahn, Agneta ^{[13
,14
]}

Storey, Robert F. ^{[15
]}

Weitz, Jeffrey I. ^{[16
,17
]}

机构：

[1] Univ G DAnnunzio, Inst Cardiol, Chieti, Italy

[2] Univ G DAnnunzio, Ctr Excellence Aging, Chieti, Italy

[3] Catholic Univ, Dept Cardiovasc Sci, Rome, Italy

[4] Oslo Univ Hosp, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway

[5] Univ Lausanne, CH-1015 Lausanne, Switzerland

[6] Wilhelminenspital Stadt Wien, Dept Med 3, Vienna, Austria

[7] Univ Southern Denmark, Inst Publ Hlth, Unit Thrombosis Res, Odense, Denmark

[8] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark

[9] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England

[10] Santo Andres Hosp, Div Cardiol, Leiria, Portugal

[11] Aalborg Univ, Dept Clin Med, Thrombosis Res Ctr, Fac Med, Aalborg, Denmark

[12] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark

[13] Uppsala Univ, Dept Med Sci, Uppsala, Sweden

[14] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden

[15] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England

[16] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada

[17] McMaster Univ, Hamilton, ON, Canada

来源：

THROMBOSIS AND HAEMOSTASIS | 2014年 / 111卷 / 05期

关键词：

ESC WORKING GROUP; ATRIAL-FIBRILLATION; HEART-DISEASE; TASK-FORCE; POSITION PAPER; THROMBOSIS; GUIDELINES;

D O I：

10.1160/TH14-03-0228

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：781 / 782

页数：2

共 12 条

[1]

[Anonymous], 2014, CHEST

[2]

Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/eurheartj/ehs253, 10.1093/europace/eus305]

[3] Vitamin K antagonists in heart disease: Current status and perspectives (Section III) [J].

De Caterina, Raffaele ;

Husted, Steen ;

Wallentin, Lars ;

Andreotti, Felicita ;

Arnesen, Harald ;

Bachmann, Fedor ;

Baigent, Colin ;

Huber, Kurt ;

Jespersen, Jorgen ;

Kristensen, Steen Dalby ;

Lip, Gregory Y. H. ;

Morais, Joao ;

Rasmussen, Lars Hvilsted ;

Siegbahn, Agneta ;

Verheugt, Freek W. A. ;

Weitz, Jeffrey I. .

THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) :1087-1107

[4] Parenteral anticoagulants in heart disease: Current status and perspectives (Section II) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease [J].

De Caterina, Raffaele ;

Husted, Steen ;

Wallentin, Lars ;

Andreotti, Felicita ;

Arnesen, Harald ;

Bachmann, Fedor ;

Baigent, Colin ;

Huber, Kurt ;

Jespersen, Jorgen ;

Kristensen, Steen Dalby ;

Lip, Gregory Y. H. ;

Morais, Joao ;

Rasmussen, Lars Hvilsted ;

Siegbahn, Agneta ;

Verheugt, Freek W. A. ;

Weitz, Jeffrey I. .

THROMBOSIS AND HAEMOSTASIS, 2013, 109 (05) :769-786

[5] General mechanisms of coagulation and targets of anticoagulants (Section I) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease [J].

De Caterina, Raffaele ;

Husted, Steen ;

Wallentin, Lars ;

Andreotti, Felicita ;

Arnesen, Harald ;

Bachmann, Fedor ;

Baigent, Colin ;

Huber, Kurt ;

Jespersen, Jorgen ;

Kristensen, Steen Dalby ;

Lip, Gregory Y. H. ;

Morais, Joao ;

Rasmussen, Lars Hvilsted ;

Siegbahn, Agneta ;

Verheugt, Freek W. A. ;

Weitz, Jeffrey I. .

THROMBOSIS AND HAEMOSTASIS, 2013, 109 (04) :569-579

[6] New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease Position Paper [J].

De Caterina, Raffaele ;

Husted, Steen ;

Wallentin, Lars ;

Andreotti, Felicita ;

Arnesen, Harald ;

Bachmann, Fedor ;

Baigent, Colin ;

Huber, Kurt ;

Jespersen, Jorgen ;

Kristensen, Steen Dalby ;

Lip, Gregory Y. H. ;

Morais, Joao ;

Rasmussen, Lars Hvilsted ;

Siegbahn, Agneta ;

Verheugt, Freek W. A. ;

Weitz, Jeffrey I. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (16) :1413-1425

[7] Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation [J].

Gallego, Pilar ;

Roldan, Vanessa ;

Marin, Francisco ;

Romera, Marta ;

Valdes, Mariano ;

Vicente, Vicente ;

Lip, Gregory Y. H. .

THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) :1189-1198

[8] European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation [J].

Heidbuchel, Hein ;

Verhamme, Peter ;

Alings, Marco ;

Antz, Matthias ;

Hacke, Werner ;

Oldgren, Jonas ;

Sinnaeve, Peter ;

Camm, A. John ;

Kirchhof, Paulus .

EUROPACE, 2013, 15 (05) :625-651

[9] Bleeding and antidotes in new oral anticoagulants [J].

Majeed, Ammar ;

Schulman, Sam .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) :191-202

[10] Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review [J].

Ogilvie, Isla M. ;

Newton, Nick ;

Welner, Sharon A. ;

Cowell, Warren ;

Lip, Gregory Y. H. .

AMERICAN JOURNAL OF MEDICINE, 2010, 123 (07) :638-U86

← 1 2 →